Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 10,867,050 $ 20,581,313
Accounts Receivable 72,609 12,510
Prepaid expenses 784,920 598,367
Other current assets 447,566 786,642
Total Current Assets 12,172,145 21,978,832
Property and equipment, net 5,393,012 4,911,077
Operating lease right-of-use assets 619,392 383,551
Intangible assets, net 110,505 216,876
Total Assets 18,295,054 27,490,336
Current Liabilities    
Accounts payable 3,043,008 1,542,457
Accrued liabilities 2,872,247 3,828,501
Deferred revenue 10,000,000 12,512
Management and directors' fees payable 71,119 71,303
Current portion of long-term debt 1,066,700 797,855
Current portion of financing lease liabilities 46,014 48,958
Current portion of operating lease liabilities 245,163 171,166
Current portion of grant repayable 41,836 43,100
Total Current Liabilities 17,386,087 6,515,852
Long-term debt, net of current portion 2,779,240 2,270,767
Finance lease liabilities, net of current portion 436,132 511,086
Operating lease liabilities, net of current portion 400,091 217,305
Grant repayable, net of current portion 420,466 253,221
Total Liabilities 21,422,016 9,768,231
Common Stock    
Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 57,873,379 shares and 53,772,261 shares, respectively 57,873 53,772
Additional paid-in capital 164,397,468 154,730,938
Accumulated other comprehensive income 227,097 148,326
Accumulated deficit (167,257,429) (136,988,636)
Total VolitionRx Limited Stockholders' Equity (Deficit) (2,574,991) 17,944,400
Non-controlling interest (551,971) (222,295)
Total Stockholders' Equity (Deficit) (3,126,962) 17,722,105
Total Liabilities and Stockholders' Equity $ 18,295,054 $ 27,490,336